4//SEC Filing
Kouchakji Elias 4
Accession 0001209191-21-015010
CIK 0000921299other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:25 PM ET
Size
7.2 KB
Accession
0001209191-21-015010
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
- Award
Common Stock
2021-02-24+20,800→ 152,567 total - Award
Stock Option (Right to Buy)
2021-02-24+39,900→ 39,900 totalExercise: $53.01Exp: 2031-02-24→ Common Stock (39,900 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- [F2]Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeother
Related Parties
1- filerCIK 0001775259
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:25 PM ET
- Size
- 7.2 KB